Ownership and insider activity for Apogee Therapeutics, Inc. (APGE): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders.
Price
| Price | $135.07 |
| Market Cap | $8.4B |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $151.9M | $118.3M | $141.8M | $131.5M |
| Short-term Investments | 0 | $277.1M | $378.9M | $598.6M |
| Receivables | 0 | $1.2M | $4.7M | $6.0M |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | $152.1M | $398.4M | $529.7M | $741.4M |
| Property, Plant & Equipment | 0 | $2.6M | $13.3M | $14.4M |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Total Assets | $152.1M | $401.4M | $754.0M | $937.1M |
| Accounts Payable | $418000 | $2.1M | $1.1M | $1.2M |
| Short-term Debt | 0 | $1.1M | $3.2M | 0 |
| Total Current Liabilities | $10.0M | $20.6M | $28.6M | $27.9M |
| Long-term Debt | 0 | 0 | 0 | $5.3M |
| Total Liabilities | $10.0M | $21.5M | $37.2M | $33.3M |
| Retained Earnings | -$39.8M | -$123.8M | -$305.9M | -$561.8M |
| Total Equity | $142.1M | $379.9M | $716.8M | $903.9M |
| Total Debt | 0 | $2.0M | $11.8M | $8.8M |
| Net Debt | -$151.9M | -$393.4M | -$508.8M | -$721.3M |
| Working Capital | $142.1M | $377.9M | $501.2M | $713.5M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 26.44 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 81.73 |
Profitability
| Return on Equity | -29.88% |
| Return on Invested Capital | -25.23% |
| Return on Assets | -22.04% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: AAPG · CELC · CGON · CNTA · IRON · LEGN · RARE
Explore sector: Healthcare · Biotechnology
More sections of APGE: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks